News Update: COVID-19
Current news topics:
- Case Counts
- Accessible version (Excel)
- Test and Hospital Data
- MIS-C Data
- Variants Data
- Vaccine Data
- Vaccination Status Data
- Public Schools
- Additional Data
The Texas Department of State Health Services tracks COVID-19 cases, testing, hospitalizations, vaccine allocations and uptake, and more.
Effective Sept. 12, 2022, the Texas COVID-19 dashboards will be updated three times per week on Mondays, Wednesdays and Fridays. In the event of a holiday, updates will occur the next business day.
COVID-19 data dashboards can be accessed from the menu options to the right.
Accessible version (Excel) | Texas COVID-19 Data Additional Datasets
All data are provisional and subject to change.
DSHS has additional information on COVID-19 for the public, health care professionals, health departments and labs at /coronavirus.
DSHS has launched a new Variants and Genomic Surveillance dashboard for SARS-CoV-2, replacing the variant count table previously located on this page. You can view the platform at /coronavirus/variants-data. The new platform is similar in style and content to the CDC’s variant dashboard, and the data shown is collected by the CDC’s national SARS-CoV-2 genomic surveillance program. The dashboard’s data will be updated weekly.
Multisystem Inflammatory Syndrome in Children (MIS-C)
MIS-C is a rare but serious complication associated with COVID-19. DSHS has launched a new multisystem inflammatory syndrome in children (MIS-C) data webpage, replacing the MIS-C count table previously located on this page. You can view the data page at /coronavirus/mis-c/mis-c-data. The data will continue to be updated monthly. DSHS is working to learn more about why some children and adolescents develop MIS-C after having COVID-19 or contact with someone with COVID-19, while others do not. An additional webpage with information and resources for parents and providers is available at /coronavirus/mis-c/mis-c-info.
Monkeypox – October 11, 2022
DSHS and local health departments are investigating cases of monkeypox that are part of an international outbreak. The disease, which can cause a serious skin rash, appears to be spreading largely via direct contact with the skin or saliva of an infected person. Most cases so far have been among men who have sex with men, so that population should be especially aware of the situation and take precautions to avoid direct contact with anyone with a rash.
Monkeypox is a preventable disease, and people have an important role to play in stopping its spread. Most cases in Texas have spread through close, intimate contact with someone who has monkeypox. Risks include having sex, kissing or hugging someone with monkeypox or sharing cups, utensils, bedding or towels with them.
Additionally, people should avoid close, skin-to-skin contact in large crowds where people are wearing minimal clothing, such as nightclubs, festivals, raves, saunas, and bathhouses. Also people should avoid close, skin-to-skin contact with someone with a new, unexplained rash.
If you were exposed to monkeypox or have symptoms such as fever, chills, swollen lymph nodes and a new, unexplained rash, contact your healthcare provider as soon as possible. You may need to be tested. If you are sick with monkeypox, stay home and avoid close contact with others until the rash has fully resolved, the scabs have fallen off, and a fresh layer of intact skin has formed.
Data updated on Tuesdays and Fridays.
|Public Health Region||Number of Cases|
|Age Category||Number of Cases|
|Sex||Number of Cases|
Monkeypox Vaccine Information
The federal government has allocated JYNNEOS vaccine to Texas for the prevention of monkeypox. JYNNEOS is a two-dose vaccine, so half the doses must be reserved to give people a second dose 28 days after the first.
DSHS has distributed vaccine to local health departments and DSHS public health regions based on the number of people currently at the greatest risk of being exposed to the monkeypox virus. DSHS has also provided updated guidance to local health departments, including on the population eligible for vaccination.
Please note that the federal government authorized a new way to administer the vaccine for most adults in early August that uses less vaccine per dose. Prior to that time, one vial contained one dose to be injected beneath the skin. In mid-August the allocation changed because each vial can now be used to inject five doses within the skin. The counts above reflect the number of doses at the time of the allocation to the state. Due to various factors, it may not be possible to get five doses out of every vial.